Paid Clinical Trials in Chesterfield, MO
As of June 2026, 60 paid clinical trials are recruiting in Chesterfield, Missouri. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Chesterfield offers studies at sites including Saint Luke's Hospital for conditions such as Idiopathic Pulmonary Fibrosis, Obesity, Progressive Pulmonary Fibrosis, AMD. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Chesterfield
Filter results
0 clinical trials
·Clear filters·↓ Download CSVAbout research studies in Chesterfield
Chesterfield has approximately 60 recruiting research studies across a wide range of therapeutic areas. Missouri hosts Washington University School of Medicine in St. Louis and University of Kansas Medical Center's Missouri partners, known for oncology, genomics, and rare-disease research.
Top Research Study Locations in Chesterfield
Researchers run research studies in Chesterfield, MO at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Luke's Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Chronic Lymphocytic Leukemia, RISS Stage I Plasma Cell Myeloma | 12 |
| The Lung Research Center, LLC | Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Interstitial Lung Disease | 7 |
| Clinical Research Professionals | Obesity, Overweight, Liver Fibrosis | 6 |
| Midwest Vision Research Foundation | Neovascular Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration, Neurotrophic Keratopathy | 5 |
| Praxis Research Site | Focal Seizure, Epilepsy, Tonic-Clonic, Focal Onset Seizure | 3 |
| Saint Louis Pain Consultants | Chronic Pain, Pain | 3 |
| Gateway Gastroenterology | Ulcerative Colitis | 2 |
| St. Luke's Hospital | Lymphoma, Narcolepsy | 2 |
| St. Luke's Hospital - Chesterfield | Non Small Cell Lung Cancer, Follicular Lymphoma (FL) | 2 |
| Bluetail Medical Group | Knee Osteoarthritis | 1 |
| Clinical Research Professionals - Headlands | Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis | 1 |
| Diabetes and Endocrinology Specialists | Hypothyroidism | 1 |
| Galen Research LLC | Agitation Associated With Alzheimer's Disease Dementia | 1 |
| Gateway Gastroenterology: 8400097 | Crohn's Disease | 1 |
| Interventional Pain Center Chesterfield - Satellite | Lumbar Spinal Stenosis | 1 |
| Interventional Pain Center of Chesterfield | Lumbar Spinal Stenosis | 1 |
| Mid America Surgery Center | AMD, CNV, Wet Age-related Macular Degeneration | 1 |
| Midwest Pain Center | Pain | 1 |
| Pepose Vision Institute | AMD | 1 |
| Pepose Vision Institute, P.C - Midwest Vision Research Foundation | Age Related Macular Degeneration (AMD) | 1 |
| Sleep Medicine and Research Center, St. Luke's Hospital | OSA | 1 |
| St. Luke's Hospital | Diastolic Heart Failure, Heart Failure, Heart Failure With Mid Range Ejection Fraction | 1 |
| St. Luke's Hospital, Sleep Medicine and Research Center | Idiopathic Hypersomnia | 1 |
| The Lung Research Center | Chronic Obstructive Pulmonary Disease | 1 |
Active & Upcoming Studies in Chesterfield (2026)
Recruiting trials in Chesterfield grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (15 active studies)
- Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma · Phase 3 · National Cancer Institute (NCI)
- Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma · Phase 3 · Genmab
Neurology & pain (7 active studies)
- Clinical Trial of Vormatrigine in Adult Patients With Epilepsy · Phase 3 · Praxis Precision Medicines
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease · Phase 2, Phase 3 · Biohaven Therapeutics Ltd.
Eye & vision (5 active studies)
- ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study · Phase 2 · Gyroscope Therapeutics Limited
- Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD · Phase 3 · AbbVie
Diabetes & metabolic (4 active studies)
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight · Phase 3 · Novo Nordisk A/S
- A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin · Phase 3 · Eli Lilly and Company
Cardiovascular (1 active study)
- Assessment of CCM in HF With Higher Ejection Fraction · Impulse Dynamics
Common conditions studied in Chesterfield
- Idiopathic Pulmonary Fibrosis (4 active studies). Recruiting Idiopathic Pulmonary Fibrosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Obesity (3 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Progressive Pulmonary Fibrosis (3 active studies). Recruiting Progressive Pulmonary Fibrosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- AMD (2 active studies). Recruiting AMD studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Anatomic Stage IV Breast Cancer AJCC v8 (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Chronic Lymphocytic Leukemia (2 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
Leading research sponsors in Chesterfield
- National Cancer Institute (NCI)
- Boehringer Ingelheim
- AbbVie
- Hoffmann-La Roche
- Praxis Precision Medicines
Local regulations and guidelines
Clinical trials in Missouri are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Missouri research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Chesterfield. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Chesterfield
Hipa.ai aggregates every recruiting study in Chesterfield from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Chesterfield?
There are approximately 60 recruiting clinical trials in Chesterfield, Missouri listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Chesterfield pay participants?
Most recruiting trials in Chesterfield compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Chesterfield?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Chesterfield?
The most common conditions under active study in Chesterfield include Idiopathic Pulmonary Fibrosis (4), Obesity (3), Progressive Pulmonary Fibrosis (3), AMD (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Chesterfield?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Chesterfield on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Chesterfield?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Chesterfield?
Recruiting research sites in Chesterfield include Saint Luke's Hospital, The Lung Research Center, LLC, Clinical Research Professionals, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Chesterfield right now?
The largest active categories in Chesterfield are Cancer & tumors (15), Neurology & pain (7), Eye & vision (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.